Nuss Procedure: Clinical Options in Pediatric Pain Management?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02009267

Enrollment

Registered

2013-12-11

Start date

2013-11-30

Completion date

2016-12-31

Last updated

2017-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pectus Excavatum

Brief summary

A retrospective chart review study analyzing the benefits of patient controlled analgesia, thoracic epidural analgesia, and paravertebral nerve block catheters in patients having surgical repair of pectus excavatum using the Nuss procedure.

Interventions

DEVICEPatient controlled analgesia

A programable electronically controlled infusion pump that delivers an amount of intravenous analgesic when the patient presses a button.

PROCEDUREContinuous thoracic epidural infusions

Continuous thoracic epidural infusions (TE) involves continuous infusion of drugs through a catheter placed into the epidural space, resulting in a loss of sensation-including the sensation of pain-by blocking the transmission of signals through nerve fibers in or near the spinal cord.

PROCEDUREContinuous paravertebral blockade

Continuous paravertebral blockade (PVB) is the technique of injecting local anesthetic adjacent to the thoracic vertebra that anesthetizes the spinal nerve roots after they exit the spinal canal.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients undergoing the NUSS procedure since the beginning of 2011 to Sept. 30th, 2013.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Total morphine dose	Participants will be followed for the duration of hospital stay, an expected average of 3 days	Total morphine dose will be evaluated in mg/kg/24 hour period, beginning with post-op day 0 until discharge from the hospital.

Secondary

Measure	Time frame	Description
Pain score	Participants will be followed for the duration of hospital stay, an expected average of 3 days	Pain scores obtained from the visual analog scale.
Length of hospitalization	Within the first week after surgery.	Determine if there is a difference in length of hospitalization, and time to discharge.
Nausea and vomiting	0-48 hrs. post-op	Determine the incidence of nausea and vomiting measured by the postoperative ondansetron dosing, beginning with arrival to floor and up to the first 48 hrs of hospitalization.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026